Albion Technology & General VCT PLC

Chairman of the Nomination Committee & Chairman of the Management Engagement Committee

Clive Richardson, (appointed 1 June 2022), Chairman, has extensive experience across a range of private and public international healthcare and technology focused f irms from start-ups to mid-cap companies. He was Head of Equities Research for Investec Bank, and worked as a strategy consultant for L.E.K. Consulting, a leading global strategy firm. He has held non-executive director roles and served as an executive board member on CIS Healthcare Limited and Clinisys Group Limited, both decision support healthcare software companies. He has served as CEO for Akari Therapeutics PLC, a NASDAQ listed biotechnology company and is currently CEO of con-join-AI, a healthcare technology company.

Chairman of the Remuneration Committee

David Benda, (appointed 26 June 2023) has extensive corporate banking experience working with investment companies providing advice on fundraising, reorganisations and restructurings. He qualified as a chartered accountant with Coopers & Lybrand in London in 1994 and whilst working for them, he took up secondment in both the New York and Prague offices until his departure in 1997. Since then, David has worked in various corporate broking roles, including for HSBC James Capel and Winterflood Securities where he focused on investment companies. David was until recently a Managing Director at Deutsche Numis where he headed up the corporate side of the listed fund team and co-headed the team overall. He is currently a non-executive director of Ecofin Global Utilities and Infrastructure Trust plc and non-executive director of Scottish Oriental Smaller Companies Trust plc.

Chairman of the Audit and Risk Committee & Senior Independent Director

Simon Thorpe, (appointed 19 December 2024), is a qualified Chartered Accountant and former chairman and director of Cambridge Angels with substantial experience of analysing and investing in early-stage public and private companies in the technology and technology enabled healthcare sectors. His previous roles include Chief Operating Officer for European Equity Research and UBS Global Equity Research. He has had over 20 years experience as a public markets equity research analyst and since then over 15 years experience as an angel investor investing in more than 60 early stage UK private companies. He sits on a number of Boards as a Non-Executive Director including Manchester University’s Technology Transfer Office, the Innovation Factory and two private software companies.

Swarupa Pathakji, (appointed 19 December 2024), has considerable experience in private equity investment, strategic development, exits and valuations. She qualified as a chartered accountant at Deloitte before spending time in mergers and acquisitions at Merrill Lynch. She moved to Duke Street, a mid-market Private Equity firm, in 2007 and has served as a non-executive director on the boards of a number of companies across multiple sectors. She is currently a non-executive director of Motorpoint Group plc and a non-executive director and chair of the audit committee of Roadside Real Estate plc.